Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients.
Kelvin Kam-Fai TsoiFelix Ch ChanHoyee W HiraiJoseph Jy SungPublished in: Journal of gastroenterology and hepatology (2018)
The long-term use of aspirin reduces both incidence and mortality of CRC and at the same time increases incidence and mortality risk of GIB. With combination use of acid-secreting agents, the bleeding risk can be reduced.
Keyphrases
- low dose
- cardiovascular events
- risk factors
- end stage renal disease
- newly diagnosed
- ejection fraction
- high dose
- chronic kidney disease
- antiplatelet therapy
- coronary artery disease
- peritoneal dialysis
- atrial fibrillation
- type diabetes
- acute coronary syndrome
- patient reported outcomes
- percutaneous coronary intervention
- patient reported